Press release
111KB
aprile 17, 2020 - Nissan
Nissan begins respirator production in Barcelona Plant
Comunicato Stampa disponibile solo in lingua originale.
- The manufacturing of Q-Vent will begin this week with the collaboration of Eurecat technology centre.
- The respirator has been designed by the R&D team of QEV Technologies to comply with international specifications for supply to developing nations.
Barcelona – Hospital de Sant Pau, the engineering company QEV Technologies, along with Nissan and the technology centre Eurecat have developed the Q-Vent respirator, to be used in hospitals throughout the world.
The accessible, flexible and reliable design meets international specifications, meaning it can be supplied to developing countries in the fight against COVID-19.
The Q-Vent has already been authorised by the Spanish Agency for Medicines and Health Products (AEMPS) and has been tested in the facilities of the Research Institute of the Hospital de Sant Pau - IIB Sant Pau (Barcelona) with excellent results. The first 20 units will be donated to the local health authority CatSalut for use in ICUs and ongoing clinical study to optimize the equipment.
"Since the beginning of the epidemic, we assumed the challenge of developing a low-cost portable system that could reach all corners of the world, especially those emerging countries where the Covid-19 was going to cause a great damage and where the majority of the patients were not going to have access to respirators. And thanks to everyone's effort and desire, this has been possible", explains Miguel Valldecabres, CEO at QEV Technologies.
"From Sant Pau we support this initiative to fight against Covid-19. We believe it is necessary to help emerging countries that have lower economic capacities than we have in Europe and that's why we support the QEV Technologies project to make this respirator useful in ICUs anywhere in the world", confirms Dr. José M. Guerra, scientific coordinator of the project, doctor of the Arrhythmia Unit of the Hospital de Sant Pau and Coordinator of the Research Group in Clinical and Translational Cardiology, of the Research Institute of this centre.
Manufacturing the Q-Vent will begin this week at Nissan Barcelona Plant's Powertrain Plant, with a capacity of 180 units per day, depending on orders.
Eurecat has been in charge of advising on the design of components and the production of some of them, as well as managing the process for the inclusion of hospitals in the clinical study.
YDRAY-01
4240x2384, 3MB
YDRAY-02
633x480, 281KB
YDRAY-03
779x724, 152KB
YDRAY-04
3024x3697, 3MB
News correlate |
||
|
|
|
aprile 17, 2024
|
aprile 17, 2024
|
aprile 15, 2024
|
|
Comunicato Stampa disponibile solo in lingua originale. Three Nissan models were honored with spots on the Cars.com® 2024 Best Val... |
Nissan Qashqai rafforza la sua identità e il suo carattere di pioniere nei crossover con un nuovo design esterno ancora più modern... |
Comunicato Stampa disponibile solo in lingua originale. BEIJING – At the 18th Beijing International Automotive Exhibition (Auto C... |
Scarica tutto 
Ti potrebbe interessare anche |
||
|
|
|
aprile 15, 2024
|
aprile 12, 2024
|
aprile 11, 2024
|
|
Nel weekend di gara presso il circuito di Misano, Rowland ottiene una vittoria importante, mentre Fenestraz si piazza nella top 10... |
Dopo un 2023 da record, nei primi tre mesi del 2024 le vendite Nissan crescono del 16% rispetto allo stesso periodo dell’anno prec... |
Il compositore tedesco Mathias Rehfeldt collabora con il Nissan Formula E Team per rilasciare una colonna sonora espressiva mixata... |
Inglese 
Scarica tutto 
Condividi
Condividi via mail 
Automotive
Sport
Events
Art&Culture
Design
Fashion&Beauty
Food&Hospitality
Tecnologia
Nautica
Racing
Excellence
Corporate
OffBeat
Green
Gift
Pop
Heritage
Entertainment
Health & Wellness